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ABSTRACT
Background: The expression of BRG1 associated factors (BAF) 155 and BAF 170 in 
response to IFN-γ or TNF-α was studied in astrocytoma cell lines and primary 
astrocytes. BAFs are complexed with BRG1 and are also associated with activated 
glucocorticoid for glucocorticoid trans-activation. Methods: IFN-γ was pretreated for 
18 hrs and cells were incubated with IL-1 or TNF-α for 72 hrs or 96 hrs with different 
concentrations of steroid. Cell death was measured by LDH assay. BAF expression was 
assayed by RT-PCR. Results: IFN-γ increased cell death by dexamethasone in LN215 
cells but not in LN319 cells. The IFN-γ increased the expression of BAF 155 and 
BAF 170 in adult astrocytes and LN215 cells, but IFN-γ decreased the expression of 
BAF 155/170 in LN319 cells. The effect of IFN-γ on the expression of BAF was 
not as clear in fetal astrocytes as it was in adult astrocytes. Conclusion: Our results 
suggest cytokines produced during immune reaction or immunotherapy may modulate 
steroid susceptibility of astrocytes and astrocytoma cells by influencing the expression 
of BAFs. (Immune Network 2004;4(4):224-228)
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Introduction
  Astrocytes represent the major portion of CNS 
(central nervous system) cells. Their main role is to 
physically protect neurons, but the function of 
astrocytes has been studied with respect to immuno-
logic activity, such as MHC class II endocytic 
pathway (1). When inflammation, tumor progression 
or a degenerative disease occurs in the CNS, T 
lymphocytes infiltrate and secrete IFN-γ or TNF-α, 
which primes further immune reactions of the 
astrocytes. 
  Astrocytoma is the most common brain tumor, and 
can be treated by steroid hormone therapy. In brain 
tumors, the metabolism of steroids is challenged 
(2). Moreover, steroid hormone receptors are 
found in astrocytomas, which are involved in the 
regulation of specific genes (3-5). Such aberrant 
control of transcription may be an important aspect 
of astrocytes acquiring immortality in the transformed 
stage. 
  Several chromatin remodeling complexes have 
been identified in recent years. Most of these are 
related to the yeast SWI/SNF complex by virtue of 
the fact that they contain a subunit that is homo-
logous to SWI2 (6). Both biochemical and genetic 
studies suggest that SWI/SNF complex antagonizes 
chromatin-mediated repression in yeast (7). The view 
that SWI/SNF-related complexes function similarly 
in other organisms is supported by the discovery of 
the BRM (Brahma) gene in Drosophila, which is 50% 
identical to SWI2/SNF2. Mammalian cells contain at 
least two genes, hBRM (human BRM) (8) and BRG 
(Brahma-related gene) (9), that are closely related to 
SWI2 and also to Brahma. Both BRG1 and hBRM 
are parts of independent complexes (9,10), which 
have nucleosome remodeling activity similar to that 
of the yeast complex (10) 
  BRG-1 complex is a human counterpart (11) of 
SNF/SWI complex of yeast. hbrm/in drosophila (12) 
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Figure 1. Cell death induced by steroid in astrocytoma cell lines in response to IFN-γ. IFN-γ was pretreated for 18 hrs and cells 
were incubated with IL-1 or TNF-α for 72 hrs or 96 hrs with different concentrations of steroid. Cell death was measured by LDH 
assay.
has an ability to remodel chromatin with ATPase 
activity. In mammalian cells, BRG-1 is complexed 
with other proteins BAFs (BRG-1 associated factors) 
(10). BAF 155 and BAF 170 is a component of com-
plex to transduce the signals in glucocorticoid 
trans-activation (13). Co-immunoprecipitation showed 
that glucocorticoids promote a hormone-dependent 
association of glucocorticoid with hBRG1 complex 
(14).
  Steroid hormones act via a group of high affinity 
receptors that regulate transcription by binding to 
hormone response elements located within the 
promoters of hormone-inducible genes (15). The 
BRG-1 complex is a human counterpart (11) of the 
SNF/SWI complex of yeast. Similar component 
hbrm in drosophila (12) has an ability to remodel 
chromatin with ATPase activity (9). 
  Among several human astrocytoma cell lines, 
LN215 and LN319 were studied in this study. These 
two cell lines have unique characteristics in response 
to oxidative stress in our previous study. LN215 cells 
were more sensitive to oxidative stress than LN319 
cells (15). 
  In this study the effect of pro-inflammatory 
cytokines on the expression of protein related to the 
chromatin remodeling complex in primary astrocytes 
or in astrocytoma cell lines was addressed. Therefore, 
the expressions of BAF 155 and BAF 170, the 
protein partners of the activated glucocorticoid were 
measured after treatment with TNF-α or IFN-γ. 
Materials and Methods
Culture of astrocytoma cell lines and the preparation of 
primary astrocytes. Fetal astrocytes were isolated from 
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Figure 4. Expression of BAF in primary 
astrocytes in response to IFN-γ, or 
TNF-α. IFN-γ was pretreated for 18 
hrs and cells were incubated with TNF-
α for 24 hrs. Semi-quantitative PCR was 
done using β-actin as an internal 
control.
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Figure 3. Expression of BAF in 
astrocytoma cells in response to IFN-γ 
or TNF-α. IFN-γ was pretreated for 18 
hrs and cells were incubated with TNF-
α for 24 hrs. Semi-quantitative PCR was 























Figure 2. Expression of BAF in astrocytoma cells and primary 
astrocytes. Semi-quantitative PCR was performed using β-actin 
as internal control.
25-week-old human fetus and adult astrocytes were 
isolated from a 30-year-old female. The samples were 
obtained from therapeutic abortion or surgery for 
epilepsy, but they were from normal brain tissue in 
both cases. Astrocytes were cultured in 10% FCS 
(Gibco BRL, Grand Island, NY)-DMEM (Gibco 
BRL, Grand Island, NY) containing 1% nonessential 
amino acids (Sigma, St. Louis, MO). The cultures 
were maintained for up to two and half months. 
Indirect fluorescence staining for GFAP (glial 
fibrillary acidic protein) revealed that most of the 
cultured cells (＞99%) were astrocytes. Astrocytoma 
cell lines, LN215 and LN319, were kindly provided 
by Dr. E. G. Van Meir (Department of Neurosur-
gery, Laboratory of Tumor Biology and Genetics, 
Lausanne, Switzerland) and maintained in 10% FCS 
containing 1% nonessential amino acids.
Treatment of cytokines and steroids. Cells were cultured 
with 750 U/ml of TNF-α (Genzyme, Cambridge, 
MA) for 24 hrs. IFN-γ (Genzyme, Cambridge, MA) 
at 100 U/ml was pretreated for 18 hrs before adding 
the TNF-α. Dexamethasone (Sigma, St. Louis, MO) 
or progesterone (Sigma, St. Louis, MO), 10-9～10-4 
M, was added to the medium 18 hrs after IFN-γ 
treatment.
Semi-quantitative reverse transcription PCR. The level of 
BAF 155 and BAF 170 mRNA was measured by 
RT-PCR. Total RNA was isolated using an RNeasy 
kit (Quiagen, Valencia, CA). Total RNA, 1 g, was 
used to synthesize cDNA with 0.1 O.D. of random 
hexamer (Pharmacia, Uppsala, Sweden) and 200 U of 
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M-MLV reverse transcriptase (Gibco BRL, Grand 
Island, NY). RT-PCR was performed using the 
following primer sets; BAF 155 primers (forward: 
5'-gCT ATC gTC TAA ACC CCC-3'; reverse: 5'-TgT 
TCA gTC CAT CCT CTT-3'), BAF 170 primers 
(forward: 5'-Acg ggg AAC Aag ggA gAg-3'; reverse: 
5'-gTA Tgg gTC TTC AAT ggg-3'). PCR conditions 
were as follows:- denaturation at 94oC for 30s, 
annealing at 57oC for 30s and extension at 72oC for 
30s. PCR buffer was 10 mM Tris-HCl (pH 10), 2.0 
mM MgCl2, 50 mM KCl with 1.25 U of Taq 
polymerase (Bioneer, Daejon, Korea). After 20 cycles, 
an additional extension at 72oC for 10 min was 
carried out. BAF 155 primers recognized the region 
between 1,544 and 1,911 in BAF 155 (GenBank 
accession No.U66615) and BAF 170 primers re-
cognized the region between 1,220 and 1,949 in BAF 
170 (GenBank accession No.U66616). PCR products 
were cloned and their sequences confirmed by 
sequencing. β-actin was used as the internal control. 
LDH assay. 100μl of 0.3 mg/ml β-NADH and 25 
μl of 22.7 mM pyruvate were added to the culture 
supernatant or cells treated with Triton X-100. O.D. 
was read under A340 immediately. 
Results
Effect of IFN-γ in astrocytoma cells for susceptibility to 
dexamethasone or progesterone. Dexamethasone did not 
induce cell death in LN215 or LN319 cells, but 
treatment with IFN-γ induced cell death in LN215 
cells at 10-8～10-4 M of dexamethasone after 72 
and 96 hrs respectively (Fig. 1A). Similar treatment 
with IFN-γ induced cell death in LN215 cells at 
10-8～10-4 M of progesterone after 72 and 96 hrs 
respectively (Fig. 1B).
Effect of IFN-γ on the expression of BAF 155 and BAF 
170 in primary astrocytes and astrocytoma cells. Basal 
expression levels of BAF 155 and BAF 170 in 
astrocytoma cell lines were almost similar to fetal 
astrocytes, as determined by intensity measurements, 
after PCR amplification (Fig. 2). Primary cultures of 
adult astrocytes expressed less BAF 155 than fetal 
astrocytes (Fig. 2). In astrocytoma cell lines the 
expression of BAF was quite different in the two cell 
lines. In LN215 cells the expression of BAF 155 and 
BAF 170 increased with IFN-γ treatment, as it did 
in primary cultures of adult astrocytes (Fig. 3). 
However, IFN-γ treatment down regulated the BAF 
155 and BAF 170 transcripts in LN319 cells. Ex-
pression patterns of BAFs in response to cytokines 
were different in the fetal and adult astrocytes. 
Although the basal expression level of BAF was low 
in adult astrocytes, the expressions of BAF 155 and 
BAF 170 were increased by IFN-γ and TNF-α. In 
particular, the co-treatment with IFN-γ and TNF-α 
increased BAF155/170 in adult astrocytes (Fig. 4). 
The overall response to cytokines in adult astrocytes 
was more prominent than in fetal astrocytes, in which 
BAF 170 mRNA transcript decreased after treatment 
with IFN-γ or after co-treatment with IFN-γ and 
TNF-α (Fig. 4). 
Discussion
  Glucocorticoid regulates several genes in astro-
cytes, inhibits the proliferation of astrocytes, and 
complex effects of steroid agonists and antagonists 
on glioma cell proliferation have been reported 
(15,17,18). Glucorcorticoid was found to down- 
regulate GFAP immunoreactivity, which may affect 
neurodegeneration (19,20). In rat astrocytoma cells 
glucocorticoid induced the expression of mRNA and 
the secretion of lipocortin (5). Steroid therapy has 
also been reported to achieve remarkable gliobla-
stoma regression (21).
  By adding IFN-γ, cell death due to dexametha-
sone was increased in LN215 cells but not in LN319 
cells. The intermediate molecules required during 
steroid signaling, BAF 155 or BAF 170, were induced 
in LN215 cells but not in LN319 cells. The BAF 155 
and 170 molecules are similar, only the proline rich 
domain is different in the C-terminal of BAF 170 
(14). In LN319 cells the transcripts of BAF 155 or 
BAF 170 were down-regulated by IFN-γ. Although 
the mechanism of variable responses to steroid or the 
expression discrepancy of BAF to cytokines in each 
astrocytoma cell lines is not clear at present, the 
possibility that cytokines may alter cellular responses 
to steroid persists (22). SWI/SNF was reported to be 
required for IFN-γ induction of CIITA, the master 
regulator of major histocompatibility complex class II 
expression (23). Despite the presence of functional 
STAT1, IRF-1 and USF-1, activators implicated in 
CIITA expression, IFN-γ did not induce CIITA in 
cells lacking BRG1 and hBRM, the ATPase subunits 
of SWI/SNF. Reconstitution with BRG1 rescued 
CIITA induction (23). Although there are a few 
studies about IFN-γ and hBRM, there is no report 
about TNF-α and hBRM until now.
  The synthetic the glucocorticoid dexamethasone 
was reported as to elevate DR5 mRNA in glio-
blastoma, ovarian cancer, and colon cancer cell lines 
with mutant p53 undergoing apoptosis, and this 
induction is inhibited by the transcriptional inhibitor 
actinomycin D. Although another glucocorticoid, 
prednisolone, also induced apoptosis, it did not 
increase DR5 mRNA (24). Therefore, dexamethasone 
and prednisolone are likely to be different in terms 
of their apoptotic mechanisms. But in the present 
study, sensitivities to dexamethasone and predni-
solone were similar in LN215 cells. After treatment 
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with IFN-γ LN215 cells became more sensitive to 
both dexamethasone and prednisolone. Steroids 
induced more cell death in LN215 cells than in 
LN319 cells. This results is compatible to our 
previous data in which up-regulation of Fas/FasL by 
oxidative stress was shown in LN215 cells, not in 
LN319 cells (15).
  As conclusions we suggest that 1) IFN-γ increases 
the expression of BAF 155 and BAF 170 in adult 
astrocytes and LN215 cells, which then became 
sensitive to steroid after treatment of IFN-γ, and 2) 
IFN-γ decreased the expression of BAF 155 and 
BAF 170 in LN319 cells, which showed no notable 
changes upon steroid treatment with IFN-γ. So the 
up-regulation of BAF might be the result of the 
malignant transformation from normal adult astro-
cytes to astrocytoma. Pro-inflammatory cytokines 
produced during the immune reaction may influence 
the steroid susceptibility of normal astrocytes and 
astrocytoma by modulating the expression of BAF 
155 and BAF 170 mRNA.
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